TrialDiabetes & metabolism journal2024

Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial.

Ji-Yeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.